[Effect of some cholinergic, adrenergic and sympatholytic compounds on the resistance of animals to acute hypoxia].
D000109:Acetylcholine / Q000627:therapeutic use; D000818:Animals; D001285:Atropine / Q000627:therapeutic use*; D003864:Depression, Chemical; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use*; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use*; D006935:Hypercapnia / Q000150:complications; D000860:Hypoxia / Q000517:prevention & control*; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013431:Sulfates; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*
D010277:Parasympathomimetics; D013431:Sulfates; D013565:Sympatholytics; D013566:Sympathomimetics; D010862:Pilocarpine; D001285:Atropine; D004809:Ephedrine; D007545:Isoproterenol; D000109:Acetylcholine; D004878:Ergotamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine; D006145:Guanethidine
Vliianie nokotorykh kholinergicheskikh, adrenergicheskikh i simpatoliticheskikh veshchestv na ustoichivost' zhivotnykh k ostroĭ gipoksii.